Source: Guideline 2022



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mathioudakis, F. Abroug, A. Agusti et al.. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations. Guideline 2022

Member's Comments

No comment yet.

Related content which might interest you: Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 243-244 Year: 2002 A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol Source: ERJ Open Res, 6 (3) 00193-2020; 10.1183/23120541.00193-2020 Year: 2020 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 Optimizing chronic obstructive pulmonary disease (COPD) diagnosis and management to reduce healthcare costs: Systematic review and modeling Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT) Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2015 Use of telehealth in the management of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 Diagnosis of chronic obstructive pulmonary disease (COPD) - are guidelines being implemented in primary care? Source: Eur Respir J 2001; 18: Suppl. 33, 347s Year: 2001 Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Source: Guideline 1995 Year: 1995 Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Variability in clinical practice for chronic obstructive pulmonary disease in outpatient clinics Source: International Congress 2015 – Different data in COPD Year: 2015 Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 182s Year: 2002